SCHEMBL2492749

SCHEMBL2492749

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 7/20 0.47
PDE4A P27815 5/20 0.47
PDE4C Q08493 5/20 0.47
PDE4D Q08499 5/20 0.47
ALOX5AP P20292 1/20 0.37
FEN1 P39748 1/20 0.37
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPK1 P28482 1/20 0.35
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
BACE1 P56817 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SQOR Q9Y6N5 1/20 0.34
POLB P06746 1/20 0.33
CYP2A6 P11509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5762985 0.81 PDE4B (0.47) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL2494994 0.81 ALDH1A1 (0.36) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL4480101 0.79 PDE4B (0.49) PDE4BPDE4APDE4CPDE4DALOX5AP
SCHEMBL3643547 0.79 NPC1 (0.54) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL2491574 0.78 MGAM (0.38) PDE4BPDE4APDE4CPDE4DMAPK1
SCHEMBL56424 0.78 PDE4B (0.47) PDE4BPDE4APDE4CPDE4DALOX5AP
SCHEMBL2491466 0.77 LTA4H (0.40) KDM4EMAPK1
SCHEMBL17038908 0.76 PDE4B (0.58) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL4870784 0.76 LMNA (0.39) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL28039230 0.75 PDE4B (0.50) PDE4BPDE4APDE4CPDE4DALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH PDE4B 3369/4885PDE4A 3692/4885PDE4C 3970/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 PDE4B 3383/4885PDE4A 3742/4885PDE4C 4030/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R PDE4B 3329/4885PDE4A 3692/4885PDE4C 4023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.